Centiva Capital’s TB SA Acquisition Corp Warrant TBSAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-40,000
Closed -$800 2003
2022
Q4
$800 Hold
40,000
﹤0.01% 1322
2022
Q3
$2K Hold
40,000
﹤0.01% 1427
2022
Q2
$4K Hold
40,000
﹤0.01% 1598
2022
Q1
$10K Hold
40,000
﹤0.01% 1532
2021
Q4
$20K Hold
40,000
﹤0.01% 1114
2021
Q3
$24K Hold
40,000
﹤0.01% 1178
2021
Q2
$40K Buy
+40,000
New +$33.6K ﹤0.01% 1292

Centiva Capital's TBSAW Position: Q1 2023 in Review

Centiva Capital sold out of TB SA Acquisition Corp Warrant (TBSAW) in Q1 2023, closing a stake of 40,000 shares — an estimated $800 sold.

Centiva Capital first reported a position in TBSAW in Q2 2021 and held it in 7 quarters. The position peaked at $40K in Q2 2021. 1 fund tracked by Wall St. Rank holds TBSAW as of Q1 2023.

  • Centiva Capital reported no remaining TB SA Acquisition Corp Warrant position as of Q1 2023 after selling out during the quarter.
  • Centiva Capital sold 40,000 TB SA Acquisition Corp Warrant shares in Q1 2023, an estimated $800.
  • Centiva Capital first reported a position in TB SA Acquisition Corp Warrant in Q2 2021 and held it in 7 quarters.
  • Centiva Capital's TB SA Acquisition Corp Warrant position peaked at $40K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held TB SA Acquisition Corp Warrant as of Q1 2023.

Based on Centiva Capital's 13F filing for Q1 2023, filed 15 May 2023.